The report "Knock
out Mice Model Pricing Analysis, by Indication, Mouse type, End users,
Discounting, Corporate Agreements, Economic Model of Demand and Supply,
Physiological Characteristics, Business Models, and Stakeholder Analysis”, analyzes
the factors that impact the pricing of knock-out mice models.
Browse 57 Pages
and in-depth TOC on "Knock out Mice Model"
will receive 10% customization on this report.
Knockout mice model market is expected to be the fastest
growing market owing to high investments in the development of new and
innovative knockout models. Development of new knockout models also increases
the application areas for the models. Knockout mice are produced by
inactivating/silencing or "knocking out" an existing gene and
replacing it with an artificial piece of DNA, thereby resulting in the loss of
gene activity. Knockout mice models are usually named after the gene that has
been inactivated. For instance, the p53 knockout mouse is named after the p53
Speak With Our Research Experts@
This gene codes for a protein that arrests cell division and suppresses
the growth of tumors, and are hence used in cancer studies. Different research
areas that widely use knockout and knock in mice include studying and modeling
different types of cancer, obesity, heart disease, diabetes, arthritis,
substance abuse, anxiety, aging, and Parkinson’s disease. Apart from widespread
use of these mice in diverse research areas, continuous introduction of new
models coupled with signing of various licensing agreements that adds to the
widened usage of the models is providing impetus for the growth of this market.
The study provides granular information regarding pricing of the
knock-out mice models with breakdown into various factors that affect the price
of the models. Some of the factors leading to price variations in the knock-out
mice models that have been analyzed in the report in detail include
indications, type of knock-out mice, agreements, discounts, demand & supply,
end-users, and physiological characteristics.
Read More | Get the Sample Pages@
For instance, the high popularity and easy availability of mice models
for diseases like cancer, diabetes, and cardiovascular diseases translates into
relatively lower prices of these models as compared to knockout mice models
that address indications such as neurological disorders and rare diseases.
Similarly, high complexity in the development of conditional knockouts makes
them expensive than constitutive and double knockout models.
Moreover, the high demand for some models translates into strong sales,
thereby enabling the sellers to reach Break Even Point (BEP) earlier which in
turn allows them to recover the cost of development. This factor plays a
crucial role in reducing the price of knockout mice models which are in high
demand. The report also provides price variations of knock-out mice for the top
players in the market.
Additionally, it provides insights to both established firms as well as
new entrants/smaller firms to gauge the price variation of Knock-out mice
models. This pricing assessment of Knock-out mice models would help
stakeholders in the market to align or re-align their business strategies with
respect to pricing of these models. Appropriate pricing of these models is
likely to translate into greater revenue share and customer base for the
stakeholders in the market.
Browse Related Reports:
Mice Model Market by Type (Inbred, Knockout, Hybrid), Technology (Microinjection, Embryonic stem Cell), Disease (Oncology, Diabetes), Service (Breeding, Quarantine, Genetic testing) & Care Products (Bedding, Feed) - Analysis & Global Forecast to 2020.
Rat Model Market by Type (Outbred, Knockout, Conditioned), Technology (Microinjection, Embryonic Stem Cells), Application (Toxicology, Oncology, CNS), Service (Breeding, Cryopreservation, Quarantine) & Care Products (Cages, Bedding, Feed) - Forecasts to 2020.
is the world’s No. 2 firm in terms of annually published premium market
research reports. Serving 1700 global fortune enterprises with more than 1200
premium studies in a year, M&M is catering to a multitude of clients across
8 different industrial verticals. We specialize in consulting assignments and
business research across high growth markets, cutting edge technologies and
newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are
tracking global high growth markets following the "Growth Engagement Model
– GEM". The GEM aims at proactive collaboration with the clients to
identify new opportunities, identify most important customers, write
"Attack, avoid and defend" strategies, identify sources of
incremental revenues for both the company and its competitors.
flagship competitive intelligence and market research platform, "RT"
connects over 200,000 markets and entire value chains for deeper understanding
of the unmet insights along with market sizing and forecasts of niche markets.
The new included chapters on Methodology and Benchmarking presented with high
quality analytical infographics in our reports gives complete visibility of how
the numbers have been arrived and defend the accuracy of the numbers.
MarketsandMarkets are inspired to help our clients grow by providing apt
business insight with our huge market intelligence repository.
Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html
Unit No. 802, 8th Floor,
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune – 411013,
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets